{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:02:16Z","timestamp":1770411736319,"version":"3.49.0"},"reference-count":16,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2009,1,3]],"date-time":"2009-01-03T00:00:00Z","timestamp":1230940800000},"content-version":"vor","delay-in-days":1251,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives\/Hypothesis:<\/jats:bold> Intranasal lysine\u2010aspirin has been used as a method of desensitization in patients with aspirin\u2010sensitive nasal polyps to control their recurrence and prevent frequent surgical intervention. However, the studies are limited in number, and their design is open to criticisms. Thus, we conducted a controlled trial to study the clinical effectiveness of topical lysine\u2010aspirin in patients with aspirin\u2010sensitive nasal polyposis.<\/jats:p><jats:p><jats:bold>Study Design:<\/jats:bold> Prospective, randomized, double blind, placebo controlled, crossover trial.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Aspirin\u2010sensitive patients confirmed by intranasal challenge were enrolled and randomized to receive 16 mg of topical lysine\u2010aspirin every 48 hours or placebo for 6 months before crossover. Polyp growth and nasal and chest symptoms were monitored using acoustic rhinometry, nasal inspiratory peak flow, peak expiratory flow rate, and a daily diary of symptom scores.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty\u2010two patients were enrolled. After withdrawals and drop outs, data were available on 11 patients for analysis. Multivariate analysis of measured parameters did not reveal a significant clinical benefit to patients receiving topical lysine\u2010aspirin compared with placebo. Deterioration was similar while on lysine\u2010aspirin or placebo.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This is the first controlled clinical trial of topical desensitization in aspirin\u2010sensitive nasal polyp patients. Despite the failure to demonstrate clinical benefit, tissue studies have shown a significant improvement at the microscopic level.<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#bib1\"><jats:sup>1<\/jats:sup><\/jats:ext-link> Further work with larger numbers of patients along with conventional treatment may show a clinical improvement in these patients.<\/jats:p>","DOI":"10.1097\/01.mlg.0000166702.38850.1b","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T08:13:05Z","timestamp":1123488785000},"page":"1385-1390","source":"Crossref","is-referenced-by-count":73,"title":["Intranasal Lysine\u2010Aspirin in Aspirin\u2010Sensitive Nasal Polyposis: A Controlled Trial"],"prefix":"10.1002","volume":"115","author":[{"given":"Abhi A.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenis K.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,3]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013508"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1979.00790190039007"},{"key":"e_1_2_5_4_2","first-page":"33","article-title":"Nasal polyps, State of the art","volume":"11","author":"Settipane GA","year":"1991","journal-title":"Rhinology"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01160.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(80)90143-8"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(83)90437-2"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90361-0"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70123-9"},{"key":"e_1_2_5_10_2","first-page":"588","article-title":"Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis","volume":"67","author":"Patriarca G","year":"1991","journal-title":"Annal Allergy"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.suppl_2.S75"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100115294"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2273.1993.tb00606.x"},{"key":"e_1_2_5_14_2","first-page":"191","article-title":"Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow","volume":"28","author":"Holmstrom M","year":"1990","journal-title":"Rhinology"},{"key":"e_1_2_5_15_2","first-page":"440","volume-title":"Anonymous Practical Statistics for Medical Research","author":"Altman DG","year":"1991"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19960530)15:10<953::AID-SIM213>3.0.CO;2-M"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(82)90081-1"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2F01.MLG.0000166702.38850.1B","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.MLG.0000166702.38850.1B","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T10:10:43Z","timestamp":1696932643000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.MLG.0000166702.38850.1B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1097\/01.MLG.0000166702.38850.1B"],"URL":"https:\/\/doi.org\/10.1097\/01.mlg.0000166702.38850.1b","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}